116 related articles for article (PubMed ID: 8414026)
1. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.
Ruttledge MH; Narod SA; Dumanski JP; Parry DM; Eldridge R; Wertelecki W; Parboosingh J; Faucher MC; Lenoir GM; Collins VP
Neurology; 1993 Sep; 43(9):1753-60. PubMed ID: 8414026
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
3. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.
Sainio M; Strachan T; Blomstedt G; Salonen O; Setälä K; Palotie A; Palo J; Pyykkö I; Peltonen L; Jääskeläinen J
Neurology; 1995 Jul; 45(7):1314-22. PubMed ID: 7617190
[TBL] [Abstract][Full Text] [Related]
4. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
5. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
6. Familial meningioma is not allelic to neurofibromatosis 2.
Pulst SM; Rouleau GA; Marineau C; Fain P; Sieb JP
Neurology; 1993 Oct; 43(10):2096-8. PubMed ID: 8413972
[TBL] [Abstract][Full Text] [Related]
7. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations.
Baser ME; Mautner VF; Ragge NK; Nechiporuk A; Riccardi VM; Klein J; Sainz J; Pulst SM
Neurology; 1996 Nov; 47(5):1269-77. PubMed ID: 8909442
[TBL] [Abstract][Full Text] [Related]
9. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
10. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
[TBL] [Abstract][Full Text] [Related]
11. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.
Watson CJ; Gaunt L; Evans G; Patel K; Harris R; Strachan T
Hum Mol Genet; 1993 Jun; 2(6):701-4. PubMed ID: 8102569
[TBL] [Abstract][Full Text] [Related]
12. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis 2 and neurilemmomatosis gene are identical.
Honda M; Arai E; Sawada S; Ohta A; Niimura M
J Invest Dermatol; 1995 Jan; 104(1):74-7. PubMed ID: 7798645
[TBL] [Abstract][Full Text] [Related]
14. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
15. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.
Evans DG; Mason S; Huson SM; Ponder M; Harding AE; Strachan T
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):361-6. PubMed ID: 9120449
[TBL] [Abstract][Full Text] [Related]
16. The parental origin of new mutations in neurofibromatosis 2.
Kluwe L; Mautner V; Parry DM; Jacoby LB; Baser M; Gusella J; Davis K; Stavrou D; MacCollin M
Neurogenetics; 2000 Sep; 3(1):17-24. PubMed ID: 11085592
[TBL] [Abstract][Full Text] [Related]
17. Regional fine mapping of the beta crystallin genes on chromosome 22 excludes these genes as physically linked markers for neurofibromatosis type 2.
Bijlsma EK; Delattre O; Juyn JA; Melot T; Westerveld A; Dumanski JP; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):112-8. PubMed ID: 7504514
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2).
Arai E; Ikeuchi T; Nakamura Y
Hum Mol Genet; 1994 Jun; 3(6):937-9. PubMed ID: 7951241
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
